Schoonenboom SN - Search Results

1

The effect of APOE genotype on clinical phenotype in Alzheimer disease.

van der Flier WM, Schoonenboom SN, Pijnenburg YA, Fox NC, Scheltens P. van der Flier WM, et al. Among authors: schoonenboom sn. Neurology. 2006 Aug 8;67(3):526-7. doi: 10.1212/01.wnl.0000228222.17111.2a. Neurology. 2006. PMID: 16894123

2

CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging.

Pijnenburg YA, Schoonenboom SN, Barkhof F, Knol DL, Mulder C, Van Kamp GJ, Van Swieten JC, Scheltens P. Pijnenburg YA, et al. Among authors: schoonenboom sn. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):246-8. doi: 10.1136/jnnp.2005.066043. J Neurol Neurosurg Psychiatry. 2006. PMID: 16421130 Free PMC article.

3

Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration.

Pijnenburg YA, Schoonenboom SN, Mehta PD, Mehta SP, Mulder C, Veerhuis R, Blankenstein MA, Scheltens P. Pijnenburg YA, et al. Among authors: schoonenboom sn. J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):735-7. doi: 10.1136/jnnp.2006.105064. Epub 2007 Mar 19. J Neurol Neurosurg Psychiatry. 2007. PMID: 17371907 Free PMC article.

4

Distribution of APOE genotypes in a memory clinic cohort.

van der Flier WM, Pijnenburg YA, Schoonenboom SN, Dik MG, Blankenstein MA, Scheltens P. van der Flier WM, et al. Among authors: schoonenboom sn. Dement Geriatr Cogn Disord. 2008;25(5):433-8. doi: 10.1159/000124750. Epub 2008 Apr 10. Dement Geriatr Cogn Disord. 2008. PMID: 18401171

5

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.

Schoonenboom SN, Visser PJ, Mulder C, Lindeboom J, Van Elk EJ, Van Kamp GJ, Scheltens PH. Schoonenboom SN, et al. Neurocase. 2005 Feb;11(1):8-13. doi: 10.1080/13554790490896785. Neurocase. 2005. PMID: 15804919

6

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

Bouwman FH, Schoonenboom SN, van der Flier WM, van Elk EJ, Kok A, Barkhof F, Blankenstein MA, Scheltens P. Bouwman FH, et al. Among authors: schoonenboom sn. Neurobiol Aging. 2007 Jul;28(7):1070-4. doi: 10.1016/j.neurobiolaging.2006.05.006. Epub 2006 Jun 19. Neurobiol Aging. 2007. PMID: 16782233

7

CSF markers related to pathogenetic mechanisms in Alzheimer's disease.

Mulder C, Schoonenboom SN, Wahlund LO, Scheltens P, van Kamp GJ, Veerhuis R, Hack CE, Blomberg M, Schutgens RB, Eikelenboom P. Mulder C, et al. Among authors: schoonenboom sn. J Neural Transm (Vienna). 2002 Dec;109(12):1491-8. doi: 10.1007/s00702-002-0763-y. J Neural Transm (Vienna). 2002. PMID: 12486489

8

Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes.

Ouwens DM, van Duinkerken E, Schoonenboom SN, Herzfeld de Wiza D, Klein M, van Golen L, Pouwels PJ, Barkhof F, Moll AC, Snoek FJ, Teunissen CE, Scheltens P, Diamant M. Ouwens DM, et al. Among authors: schoonenboom sn. Diabetologia. 2014 Oct;57(10):2208-14. doi: 10.1007/s00125-014-3333-6. Epub 2014 Jul 18. Diabetologia. 2014. PMID: 25034377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page